You just read:

European Medicines Agency Validates the Marketing Authorization Application for Avelumab for the Treatment of Metastatic Merkel Cell Carcinoma

News provided by

Merck KGaA, Darmstadt, Germany, and Pfizer

Oct 31, 2016, 03:00 ET